{"id":"NCT00325468","sponsor":"Amgen","briefTitle":"An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density","officialTitle":"An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05-01","primaryCompletion":"2011-03-28","completion":"2012-08-02","firstPosted":"2006-05-12","resultsPosted":"2013-07-30","lastUpdate":"2017-08-01"},"enrollment":200,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Low Bone Mineral Density"],"interventions":[{"type":"DRUG","name":"AMG 162","otherNames":[]}],"arms":[{"label":"AMG 162","type":"EXPERIMENTAL"}],"summary":"An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women with Low Bone Mineral Density","primaryOutcome":{"measure":"Lumbar Spine Bone Mineral Density Percent Change From Parent Study 20010223 Baseline to Year 8","timeFrame":"8 years","effectByArm":[{"arm":"Placebo","deltaMin":8.4,"sd":null},{"arm":"Denosumab 210 mg Q6M","deltaMin":11.2,"sd":null},{"arm":"Denosumab 30 mg Q3M","deltaMin":11,"sd":null},{"arm":"Denosumab Continuous Treatment","deltaMin":16.5,"sd":null},{"arm":"Alendronate 70mg QW","deltaMin":12.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21159841"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":23},"commonTop":["Upper respiratory tract infection","Arthralgia","Back pain","Hypertension","Sinusitis"]}}